Results 11 to 20 of about 47,567 (220)

Precursor NK cell lymphoblastic leukemia/lymphoma - report of a case with literature review [PDF]

Mediterranean Journal of Hematology and Infectious Diseases, 2014
Precursor Natural Killer cell lymphoblastic leukemia/lymphoma is a rare entity defined clearly by WHO (2008 WHO classification). However, the pathobiology of this subset of neoplasms is not clearly defined.
Sonal Jain, Rajeev Kumar, Abhishek Purohit, Hara Prasad Pati   +3 more
doaj   +3 more sources

Precursor B-Cell Acute Lymphoblastic Leukemia/Lymphoma with L3 Morphology, Philadelphia Chromosome, MYC Gene Translocation, and Coexpression of TdT and Surface Light Chains: A Case Report

Case Reports in Pathology, 2013
Acute lymphoblastic leukemia is predominantly found in children. It is a neoplasm of precursor cells or lymphoblasts committed to either a B- or T-cell lineage.
Alicia C. Hirzel, Aaron Cotrell, Robert Gasparini, Vathany Sriganeshan   +3 more
doaj   +4 more sources

Precursor T-Cell acute lymphoblastic leukemia/lymphoma with rare presentation in the urinary bladder [PDF]

Hematology Reports, 2011
We present the 16th reported case of Acute Lymphoblastic Leukemia (ALL) with involvement in the bladder. Our patient was a 22 yearold man with T-cell ALL with a mediastinal mass.
Alexander Pham, Amir Steinberg, Brian Kwok, Angela Lopez, Stephen Lim, Michael Lill   +5 more
doaj   +3 more sources

Incidence of Hodgkin and Non-Hodgkin Lymphomas: Comparison of the Military and General Population. [PDF]

Cancer Med
ABSTRACT Background Lymphoma risk varies by demographics, environmental/occupational exposures, and medical care between active‐duty service members (ADSM) and the general US population (GUSP). This study compared age‐adjusted incidence rates and trends of Hodgkin lymphoma (HL) and non‐Hodgkin lymphoma (NHL) between these groups.
Robins KR, Bytnar JA, DeStefano CB, Shriver CD, Zhu K.   +4 more
europepmc   +2 more sources

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia [PDF]

New England Journal of Medicine, 2017
BACKGROUND Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts, was approved for use in patients with relapsed or refractory B ...
Arslan, O, Bassan, R, Bergeron, J, Brueggemann, M, Demirkan, F, Dombret, H, Fielding, AK, Fleishman, A, Foa, R, Goekbuget, N, Holland, C, Horst, H-A, Kantarjian, H, Klapper, W, Lech-Maranda, E, Nagorsen, D, Rambaldi, A, Ribera, J-M, Sanz, MA, Schuh, AC, Stein, A, Thomas, X, Topp, MS, Wei, A, Wood, BL, Zimmerman, Z   +25 more
core   +5 more sources

Isolated Central Nervous System Presentation of Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma: A Rare Case of Exclusive Brain Involvement

Case Reports in Hematology
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) is a high-risk and biologically distinct subset of T-cell acute lymphoblastic leukemia, typically characterized by leukemic involvement of bone marrow, peripheral blood, and ...
Violet O. Swart, Behyar Zoghi
doaj   +2 more sources

A Bibliometric Analysis of Drug Resistance in Pediatric Acute Lymphoblastic Leukemia [PDF]

Advanced Biomedical Research
Background: Despite the improved outcomes in acute lymphoblastic leukemia (ALL), drug resistance remains a major challenge. This study provides the first overview of global research trends in pediatric ALL drug resistance, highlighting emerging ...
Alireza Khanahmad, Mohammad Hossein Khazaee-Nasirabadi, Mahshid Lotfi, Amir Hami   +3 more
doaj   +2 more sources

Biopharmaceuticals for Cancer Treatment: An Update [PDF]

Cancer Med
ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Nath A, Alam Y, Mim A, Akter M, Gani M, Alam K, Alam M.   +6 more
europepmc   +2 more sources

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma [PDF]

Biomarker Research, 2022
AbstractPatients with relapsed/refractory early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) respond poorly to traditional therapy and have dismal prognosis. CD7 is a promising therapeutic targets for chimeric antigen receptor modified T cell therapy (CART) due to its widely expression in almost all T-cell malignancies.
Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang   +9 more
openaire   +4 more sources

CBFA2T3::GLIS2‐positive acute leukemia with RAM and mixed T/megakaryocytic phenotype

eJHaem, 2023
Herein, we present a rare case of acute myeloid leukemia (AML) with CBFA2T3‐rearrangement and the expression of megakaryocytic and lymphoid markers, highlighting the need for a high suspicion index in differential diagnosis and applying adequate workup ...
Mahsa Khanlari, Lu Wang, Christine Y Bolen, Felipe Sebastian Bautista Otanez, Larissa V. Furtado, Laura Key, Lisa Irwin, Wei Wang, Jeffery M. Klco   +8 more
doaj   +1 more source